Recurrent Campylobacter jejuni Infections with <i>In Vivo</i> Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants-Reference-Cited by-同舟云学术

Recurrent Campylobacter jejuni Infections with In Vivo Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants

Published:2023-08-17 Issue:4 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Nunes Alexandra¹²^ORCID,Oleastro Mónica¹^ORCID,Alves Frederico¹,Liassine Nadia³,Lowe David M.⁴,Benejat Lucie⁵,Ducounau Astrid⁵,Jehanne Quentin⁵,Borges Vítor¹,Gomes João Paulo¹²^ORCID,Godbole Gauri⁶,Philippe Lehours⁵⁷

Affiliation:

1. Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal

2. Faculty of Veterinary Medicine, Lusófona University, Lisbon, Portugal

3. Laboratoire Dianalabs, Geneva, Switzerland

4. University College London, London, United Kingdom

5. French National Reference Centre for Campylobacters and Helicobacters, Bordeaux Hospital University Centre, Bordeaux, France

6. UK Health Security Agency, London, United Kingdom

7. University of Bordeaux, INSERM, Bordeaux Institute of Oncology, Bordeaux, France

Abstract

Carbapenem susceptibility patterns suggest drug impermeability, related to either insertion and/or single nucleotide polymorphism (SNP) within por A. Similar molecular events occurring in two independent cases support the association of these mechanisms with carbapenem resistance in Campylobacter spp.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01070-23

Reference55 articles.

1. Microbe Profile: Campylobacter jejuni – survival instincts

2. The European Union One Health 2020 Zoonoses Report;EFSA, ECDC;EFSA J,2021

3. The Evolution ofCampylobacter jejuniandCampylobacter coli

4. Host-Pathogen Interactions inCampylobacterInfections: the Host Perspective

5. The clinical importance of emerging Campylobacter species

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occurrence of in vivo carbapenem-resistant Campylobacter coli mediated by porA point mutation and overexpression of blaOXA-489 under meropenem treatment;Clinical Microbiology and Infection;2024-07

2. Epidemiological Data and Antimicrobial Resistance of Campylobacter spp. in Portugal from 13 Years of Surveillance;Pathogens;2024-02-06

3. Effect of the polysaccharide capsule and its heptose on the resistance of Campylobacter jejuni to innate immune defenses;MicrobiologyOpen;2024-02

4. Erratum for Nunes et al., “Recurrent Campylobacter jejuni Infections with In Vivo Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants”;Microbiology Spectrum;2023-12-12

5. Azithromycin/ertapenem/meropenem;Reactions Weekly;2023-09-16